Accelerate Diagnostics Posts Q3 Revenue Gain | GenomeWeb

NEW YORK (GenomeWeb News) – Accelerate Diagnostics today reported that revenues for its third quarter jumped 151 percent year over year.

Revenues for the three months ended Sept. 30 rose to $12,797 from $5,115 in the year-ago period "due to fluctuations in partner sales volumes on which royalties were due the company," Accelerate said in its quarterly earnings document filed with the US Securities and Exchange Commission.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Theresa May tries to reassure researchers about the UK's commitment to science, New Scientist reports.

In Science this week: new single-cell RNA sequencing technique to study proliferating cells, and more.

South African researchers uncover bone cancer in an ancient hominin ancestor.

English bulldogs suffer from low genetic diversity and might have to be outbred to improve their health, according to a new study.